logo

For the Inventor, By the Inventor

Bend, OR, United States of America

Fred Jordan

LinkedIn

This inventor holds 23 USPTO granted patents and 5 published patent applications and 2 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Deciphera Pharmaceuticals, LLC, Other. Active years: 1976-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fred Jordan. Retrieved from https://idiyas.com/inventor/fred-jordan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 95.7

 

Average Co-Inventor Count = 3.7

ph-index = 8

Forward Citations = 232(Granted Patents)


Location History:

  • Whittier, CA (US) (1976)
  • Bend, OR (US) (2021 - 2024)

Company Filing History:

goldMedal21 out of 99 
 
Deciphera Pharmaceuticals, LLC
 patents
silverMedal2 out of 834,570 
Other
 patents

Years Active: 1976-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Amorphous Kinase Inhibitors
Formulations
Novel Compounds
Precision Sequencing
Ball Retainer
Telescoping Drawer Slide
Pharmaceutical Applications
Dihydro-Naphthyridine
23 patents (USPTO):Explore Patents
1. 12708617 - AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF (2026-08-18),
2. 12318374 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-06-03),
3. 12226406 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-02-18),
4. 12213968 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-02-04),
5. 12213967 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-02-04),
6. 12064422 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-08-20),
7. 12023328 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-07-02),
8. 11969415 - (methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-04-30),
9. 11918564 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-03-05),
10. 11911370 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-02-27),
11. 11903933 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-02-20),
12. 11896585 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea (2024-02-13),
13. 11850241 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2023-12-26),
14. 11850240 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2023-12-26),
15. 11844788 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2023-12-19),

Title: The Innovative Contributions of Fred Jordan in Pharmaceutical Research

Introduction: Fred Jordan, based in Bend, Oregon, has made significant strides in the field of pharmaceuticals with his impressive portfolio of 19 patents. His work predominantly focuses on the development of innovative compounds aimed at treating critical disorders, showcasing his dedication to advancing medical science.

Latest Patents: Among his latest patents, Fred has developed low impurity compositions, notably a compound represented by Formula (I): 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea. This composition is particularly useful in treating disorders related to the activity of c-KIT and PDGFRα kinases and their oncogenic forms. These innovative formulations hold promise in the pharmaceutical sector.

Career Highlights: Fred Jordan is currently employed at Deciphera Pharmaceuticals, LLC, where he dedicates his efforts towards groundbreaking research and drug development. His extensive experience and innovative thinking have positioned him as a key contributor in his field.

Collaborations: Throughout his career, Fred has collaborated with talented coworkers such as Scott Bone and Corey Bloom. These collaborations have fostered an environment of creativity and innovation, driving forward the research and development initiatives at Deciphera Pharmaceuticals.

Conclusion: Fred Jordan's contributions to pharmaceutical innovations through his 19 patents exemplify his commitment to improving healthcare outcomes. His latest innovations pave the way for potential advancements in treatment options, further consolidating his reputation as a leader in the industry. As he continues to work alongside esteemed colleagues, his impact on the field is undeniably significant.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…